Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN).

Author:

Geoerger Birgit1,Moertel Christopher L.2,Whitlock James3,McCowage Geoffrey Brian4,Kieran Mark W.5,Broniscer Alberto6,Hargrave Darren R7,Hingorani Pooja8,Kilburn Lindsay Baker9,Mueller Sabine10,Tseng Lillian11,Nebot Noelia11,Dasgupta Kohinoor12,Russo Mark W.11,Fox Elizabeth13

Affiliation:

1. Gustave Roussy, Villejuif, France;

2. University of Minnesota Masonic Children’s Hospital, Minneapolis, MN;

3. The Hospital for Sick Children, University of Toronto, Toronto, ON;

4. Department of Oncology, Children's Hospital at Westmead, Sydney, Australia;

5. Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA;

6. St. Jude Children's Research Hospital, Memphis, TN;

7. Great Ormond Street Hospital for Children, London, United Kingdom;

8. Phoenix Children's Hospital, Phoenix, AZ;

9. Children's National Medical Center, Washington, DC;

10. University of California, San Francisco, San Francisco, CA;

11. Novartis Pharmaceuticals Corporation, East Hanover, NJ;

12. Novartis Healthcare Pvt. Ltd., Hyderabad, India;

13. Children's Hospital of Philadelphia, Philadelphia, PA;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3